Chronic Migraine With Apparent Loss of Response to Onabotulinum Toxin Type A Due to Local Nitroglycerin Treatment for an Anal Fissure: A Case Report.
chronic migraine
nitroglycerin
onabotulinum toxin type A
Journal
Headache
ISSN: 1526-4610
Titre abrégé: Headache
Pays: United States
ID NLM: 2985091R
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
11
04
2020
revised:
15
04
2020
accepted:
16
04
2020
pubmed:
4
6
2020
medline:
16
11
2021
entrez:
4
6
2020
Statut:
ppublish
Résumé
Many patients with chronic migraine are difficult to treat. We present a patient with chronic migraine with good response to onabotulinum toxin type A whose headaches worsened in clear temporal relationship to local treatment with glyceryl trinitrate for an anal fissure. Our case shows that the use, even at distance, of nitric oxide donors can be a precipitating factor for migraineurs and should be always inquired in chronic migraine patients. In addition, the presence of frequent headaches should always be ruled out before prescribing such medications.
Substances chimiques
Neuromuscular Agents
0
Nitric Oxide Donors
0
Ointments
0
Botulinum Toxins, Type A
EC 3.4.24.69
onabotulinum toxin A
EC 3.4.24.69
Nitroglycerin
G59M7S0WS3
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2570-2572Informations de copyright
© 2020 American Headache Society.
Références
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the generalpopulation. Headache. 1999;39:190-196.
Guitera V, Muñoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: A study in a general population. Neurology. 2002;58:1062-1065.
Cernuda-Morollón E, Ramón C, Larrosa D, et al. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year? Cephalalgia. 2015;35:864-868.
Negro A, Curto M, Loinetto L, Marteletti P. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: A real-world experience. J Headache Pain. 2015;17:1.
Berry SM, Barish CF, Clark G, et al. Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: A randomized, double-blind, placebo-controlled study. BMC Gastroenterol. 2013;13:106.
Ashina M, Hansen JM, A Dunga BO, Olesen J. Human models of migraine - Short-term pain for long-term pain. Nat Rev Neurol. 2017;13:713-724.
Brisinda G, Maria G, Bentivoglio AR, et al. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. New Engl J Med. 1999;341:65-69.